To further investigate cytogenetic abnormalities in AML patients with and without aberrant methylation levels of the CTNNA1 gene, we analyzed the differences of various karyotype abnormalities between the two groups. The gene discussed is CTNNA1; the disease is acute myeloid leukemia.